Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-06-02FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for nicardipine hydrochloride from Civica, Inc., signaling regulatory approval of a supplement to th…
-
FDA approval · 2015-06-02FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved Mylan's supplemental application for Bisoprolol Fumarate and Hydrochlorothiazide, enabling a generic product. This combinat…
-
FDA approval · 2015-06-01FDA Approved: AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's original ANDA for a fixed-dose combination of amlodipine besylate, valsartan, and hydrochlorot…
-
FDA approval · 2015-05-29FDA Approved: CLONIDINE — Supplemental Application (Dr. Reddy's Labratories Inc.)
FDA approved a supplemental application for clonidine from Dr. Reddy's Laboratories Inc., granting continued regulatory approval of a generi…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Urgent Medical and Surgical Conditions During Flights
Clinical trial NCT02457455 investigating urgent medical and surgical conditions during flights has completed, examining scenarios such as sy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: The Effect of Cocoa Flavonoids on Blood Pressure [NA]
This completed trial evaluated whether cocoa flavonoids can lower blood pressure in individuals with hypertension. The study's results have …
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2) [NA]
Trial update for a study on free fatty acids-induced hypertension in obese subjects is completed with posted results.
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Understanding and Appraising the New Medicine Service in England [NA]
Completed clinical trial evaluating the understanding and appraisal of the New Medicine Service in England.
-
CLINICAL_TRIALS research · 2015-05-27Clinical Trial Update: Meta-analyses of the Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome
A meta-analysis examining how tree nut consumption affects glycemic control and features of the metabolic syndrome.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: The Use of a Community-based Organization to Change Lifestyle Characteristics Related to Non Communicable Diseases [NA]
Clinical trial update indicating completion of a community-based lifestyle intervention study. The study targeted diabetes, hypertension, st…
-
CLINICAL_TRIALS research · 2015-05-27Clinical Trial Update: Meta-analyses of Fructose and Cardiometabolic Risk
This document provides an update on meta-analyses examining the relationship between fructose intake and cardiometabolic risk factors.
-
FDA approval · 2015-05-22FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Diovan HCT (valsartan/hydrochlorothiazide) from Novartis Pharmaceuticals Corporation.
-
FDA label_change · 2015-05-22FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA is processing a supplemental application for EXFORGE (amlodipine besylate and valsartan) from Novartis Pharmaceuticals, related to a lab…
-
FDA approval · 2015-05-21FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application to add Cardene IV (nicardipine hydrochloride) as an intravenous formulation for use when oral th…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Patients [NA]
A completed clinical trial evaluating the safety and efficacy of renal artery ablation for resistant hypertension. Results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril [NA]
A completed clinical trial comparing hydrochlorothiazide and lisinopril for hypertension.
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Pharmaceutical Care in Emergency Department [NA]
A completed clinical trial evaluating pharmaceutical care in the Emergency Department with a focus on medication adherence and hypertension …
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Onion, Cardiovascular Risk Markers and Gene Expression [NA]
Completed clinical trial investigating the effect of onion on cardiovascular risk markers and gene expression, including measurements relate…
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Pharmacogenomic Evaluation of Antihypertensive Responses 2 [Phase 4]
Phase 4 clinical trial update reporting results from a pharmacogenomic evaluation of antihypertensive responses.
-
CLINICAL_TRIALS research · 2015-05-19Clinical Trial Update: Effects of Inspiratory Muscle Training on Blood Pressure Levels in Hypertensive Individuals [NA]
Clinical trial update investigating the effects of inspiratory muscle training on blood pressure in people with hypertension.
-
CLINICAL_TRIALS withdrawal · 2015-05-19Clinical Trial Update: Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries [Phase 2]
A Phase 2 trial comparing aliskiren versus hydrochlorothiazide in patients with hypertension and type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-19Clinical Trial Update: Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects [Phase 2]
Phase 2 trial comparing losartan to hydrochlorothiazide in adults with pre-hypertension and pre-diabetes; the study status has been terminat…
-
FDA label_change · 2015-05-18FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) from Novartis, resulting in changes to…
-
FDA approval · 2015-05-18FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application (AP) for a generic fixed-dose combination of losartan potassium and hydrochlorothiazide from NorthSt…
-
FDA approval · 2015-05-18FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' valsartan and hydrochlorothiazide combination via a supplemental application. This action updates the la…